Sun Rong-qing, Shi Xiao-yi, Yang Hong-fu, Hao Qian-meng, Zhu Li-chao, Liu Qi-long, Niu Jing-jing
Department of Critical Care Medicine, the First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China. Corresponding author: Sun Rong-qing, Email:
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2013 Nov;25(11):681-5. doi: 10.3760/cma.j.issn.2095-4352.2013.11.011.
To determine the dynamic change in serum levels of activin A (ACTA) and C-reaction protein (CRP) in patients with brain injury, and to investigate its significance.
A prospective study was conducted. A total of 57 adult patients with brain injury occurring within 24 hours admitted to intensive care unit (ICU) of the First Affiliated Hospital of Zhengzhou University from August 2012 to June 2013 were enrolled. The patients were allocated into three groups according to their Glasgow coma scale (GCS) as follows: minor brain injury (GCS 13-15, n=17), moderate brain injury (GCS 9-12, n=18), heavy brain injury (GCS 3-8, n=22). The clinical and related laboratory data (reflecting the function of liver, kidney, lung, blood coagulability etc.) were recorded after ICU admission. At the same time, venous samples were collected on the day 1, 2, 3, 5, 7 after ICU admission for determination of ACTA with enzyme linked immunosorbent assay (ELISA) and CRP with fluorescence immunoassay technology. The correlation between ACTA and CRP was analyzed by linear correlation. The receiver operating characteristic (ROC) curve was plotted to analyze the accuracy of ACTA and CRP as a prognostic indicator in brain injury. Fifteen healthy persons were enrolled as the control group.
The serum levels of ACTA and CRP in patients with minor, moderate and heavy brain injury were significantly higher than those in healthy control group [ACTA (μg/L): 23.96±3.55, 42.06±5.67, 52.32±4.46 vs. 13.66±2.45, all P<0.01; CRP (mg/L): 14.12±2.45, 23.05±2.85, 30.93±2.35 vs. 3.42±2.25, all P<0.01]. As the patients' condition worsening, levels of ACTA and CRP tended to elevate (all P<0.01). Levels of ACTA and CRP in minor, moderate and heavy brain injury groups were increased after ICU admission. On day 3, levels of serum ACTA and CRP reached the peak values [ACTA (μg/L):30.62±2.54, 51.35±2.55, 60.52±2.55; CRP (mg/L): 18.62±2.64, 30.35±2.25, 37.52±2.55], and then they lowered gradually. In minor and moderate brain injury groups, the levels of ACTA and CRP were slowly descending, and on day 7, they maintained at a lower level [ACTA (μg/L): 13.68±2.54, 37.74±2.55; CRP (mg/L): 6.68±2.44, 19.74±2.55]. On the contrary, the levels of ACTA and CRP in heavy brain injury group persistently maintained at a high level on day 7 [ACTA: (42.32±2.54) μg/L, CRP: (33.32±2.56) mg/L]. There were significant differences in ACTA and CRP among different degrees of brain injury groups (all P<0.01). There was a positive correlation between ACTA and CRP (r=0.958, P=0.007). ROC curve analysis showed that the sensitivity for brain injury prediction was 93.3% for ACTA with specificity 95.0%, area under ROC curve(AUC) 0.843, and the sensitivity for CRP was 89.1% with specificity 68.2%, AUC 0.723.
Serum levels of ACTA and CRP in patients with brain injury are strongly correlated with the severity of the injury. Furthermore, ACTA is more sensitive than CRP in detecting early brain injury. Therefore, ACTA is a specific factor for detecting brain injury.
测定脑损伤患者血清中激活素A(ACTA)和C反应蛋白(CRP)水平的动态变化,并探讨其意义。
进行一项前瞻性研究。选取2012年8月至2013年6月在郑州大学第一附属医院重症监护病房(ICU)收治的24小时内发生脑损伤的57例成年患者。根据格拉斯哥昏迷量表(GCS)将患者分为三组:轻度脑损伤(GCS 13 - 15,n = 17)、中度脑损伤(GCS 9 - 12,n = 18)、重度脑损伤(GCS 3 - 8,n = 22)。记录ICU入院后患者的临床及相关实验室数据(反映肝、肾、肺功能及凝血功能等)。同时,在ICU入院后第1、2、3、5、7天采集静脉血样,采用酶联免疫吸附测定(ELISA)法测定ACTA,采用荧光免疫测定技术测定CRP。通过线性相关分析ACTA与CRP之间的相关性。绘制受试者工作特征(ROC)曲线,分析ACTA和CRP作为脑损伤预后指标的准确性。选取15名健康人作为对照组。
轻度、中度和重度脑损伤患者血清ACTA和CRP水平均显著高于健康对照组[ACTA(μg/L):23.96±3.55,42.06±5.67,52.32±4.46 对比 13.66±2.45,P均<0.01;CRP(mg/L):14.12±2.45,23.05±2.85,30.93±2.35 对比 3.42±2.25,P均<0.01]。随着患者病情加重,ACTA和CRP水平呈上升趋势(P均<0.01)。ICU入院后,轻度、中度和重度脑损伤组的ACTA和CRP水平均升高。第3天,血清ACTA和CRP水平达到峰值[ACTA(μg/L):30.62±2.54,51.35±2.55,60.52±2.55;CRP(mg/L):18.62±2.64,30.35±2.25,37.52±2.55],随后逐渐下降。在轻度和中度脑损伤组,ACTA和CRP水平缓慢下降,第7天时维持在较低水平[ACTA(μg/L):13.68±2.54,37.74±2.55;CRP(mg/L):6.68±2.44,19.74±2.55]。相反,重度脑损伤组第7天时ACTA和CRP水平持续维持在较高水平[ACTA:(42.32±2.54)μg/L,CRP:(33.32±2.56)mg/L]。不同程度脑损伤组之间ACTA和CRP存在显著差异(P均<0.01)。ACTA与CRP呈正相关(r = 0.958,P = 0.007)。ROC曲线分析显示,ACTA预测脑损伤的敏感性为93.3%,特异性为95.0%,ROC曲线下面积(AUC)为0.843;CRP的敏感性为89.1%,特异性为68.2%,AUC为0.72三。
脑损伤患者血清ACTA和CRP水平与损伤严重程度密切相关。此外,ACTA在检测早期脑损伤方面比CRP更敏感。因此,ACTA是检测脑损伤的一个特异性指标。